321
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Ex vivo challenge models for infectious diseases

, , , , , , & show all
Received 03 Feb 2023, Accepted 09 Oct 2023, Published online: 01 Nov 2023

References

  • Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, et al. 2009. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: Implications for the epidemic. J Virol. 83(11):5592–5605. doi: 10.1128/JVI.02051-08.
  • Ackermann K, Borgia SL, Korting HC, Mewes KR, Schafer-Korting M. 2010. The Phenion Full-Thickness Skin Model for percutaneous absorption testing. Skin Pharmacol Physiol. 23(2):105–112. doi: 10.1159/000265681.
  • Agonia AS, Palmeira-de-Oliveira A, Cardoso C, Augusto C, Pellevoisin C, Videau C, Dinis-Oliveira RJ, Palmeira-de-Oliveira R. 2022. Reconstructed human epidermis: An alternative approach for in vitro bioequivalence testing of topical products. Pharmaceutics. 14(8):1554. doi: 10.3390/pharmaceutics14081554.
  • Alepee N, Grandidier MH, Cotovio J. 2019. Usefulness of the EpiSkin reconstructed human epidermis model within Integrated Approaches on Testing and Assessment (IATA) for skin corrosion and irritation. Toxicol in Vitro. 54:147–167. doi: 10.1016/j.tiv.2018.09.015.
  • Alfi O, Yakirevitch A, Wald O, Wandel O, Izhar U, Oiknine-Djian E, Nevo Y, Elgavish S, Dagan E, Madgar O, et al. 2021. Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract. J Virol. 95(14):e0013021. doi: 10.1128/JVI.00130-21.
  • Ambike S, Cheng CC, Feuerherd M, Velkov S, Baldassi D, Afridi SQ, Porras-Gonzalez D, Wei X, Hagen P, Kneidinger N, et al. 2022. Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread. Nucleic Acids Res. 50(1):333–349. doi: 10.1093/nar/gkab1248.
  • Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, Elliott J, Janocko L, Khanukhova E, Dennis R, et al. 2012. RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retroviruses. 28(11):1412–1421. doi: 10.1089/aid.2012.0262.
  • Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Fleming LB, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, et al. 2021. Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. J Clin Invest. 131(16):e146975.
  • Ayehunie S, Cannon C, Lamore S, Kubilus J, Anderson DJ, Pudney J, Klausner M. 2006. Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products. Toxicol in Vitro. 20(5):689–698. doi: 10.1016/j.tiv.2005.10.002.
  • Baldassi D, Ambike S, Feuerherd M, Cheng CC, Peeler DJ, Feldmann DP, Porras-Gonzalez DL, Wei X, Keller LA, Kneidinger N, et al. 2022. Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. J Control Release. 345:661–674. doi: 10.1016/j.jconrel.2022.03.051.
  • Bayyoud T, Vavouras Syrigos G, Ruetalo Buschinger N, Wude J, Businger R, Hu D, Iftner A, Thaler S, Schindler M. 2023. Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells. Graefes Arch Clin Exp Ophthalmol. 261(2):435–446. doi: 10.1007/s00417-022-05776-6.
  • Berry N, Stein M, Ferguson D, Ham C, Hall J, Giles E, Kempster S, Adedeji Y, Almond N, Herrera C. 2022. Mucosal responses to Zika virus infection in cynomolgus Macaques. Pathogens. 11(9):1033. doi: 10.3390/pathogens11091033.
  • Bestion E, Halfon P, Mezouar S, Mege JL. 2022. Cell and animal models for SARS-CoV-2 research. Viruses. 14(7):1507. doi: 10.3390/v14071507.
  • Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 193(11):1478–1486. doi: 10.1086/503780.
  • Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, Fehler G, Morrow A, Walker S, Vodstrcil LA, et al. 2012. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: Randomised placebo-controlled double-blind trial. PLoS One. 7(4):e34540. doi: 10.1371/journal.pone.0034540.
  • Brown JL, Johnston W, Delaney C, Rajendran R, Butcher J, Khan S, Bradshaw D, Ramage G, Culshaw S. 2019. Biofilm-stimulated epithelium modulates the inflammatory responses in co-cultured immune cells. Sci Rep. 9(1):15779. doi: 10.1038/s41598-019-52115-7.
  • Bui CHT, Yeung HW, Ho JCW, Leung CYH, Hui KPY, Perera R, Webby RJ, Schultz-Cherry SL, Nicholls JM, Peiris JSM, et al. 2021. Tropism of SARS-CoV-2, SARS-CoV, and influenza virus in canine tissue explants. J Infect Dis. 224(5):821–830. doi: 10.1093/infdis/jiab002.
  • Cavarelli M, Foglieni C, Rescigno M, Scarlatti G. 2013. R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5. EMBO Mol Med. 5(5):776–794. doi: 10.1002/emmm.201202232.
  • Cekici A, Kantarci A, Hasturk H, Van Dyke TE. 2014. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 64(1):57–80. doi: 10.1111/prd.12002.
  • Chu H, Chan JF, Wang Y, Yuen TT, Chai Y, Hou Y, Shuai H, Yang D, Hu B, Huang X, et al. 2020. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 71(6):1400–1409. doi: 10.1093/cid/ciaa410.
  • Chu H, Chan JF, Wang Y, Yuen TT, Chai Y, Shuai H, Yang D, Hu B, Huang X, Zhang X, et al. 2021. SARS-CoV-2 induces a more robust innate immune response and replicates less efficiently than SARS-CoV in the human intestines: An ex vivo study with implications on pathogenesis of COVID-19. Cell Mol Gastroenterol Hepatol. 11(3):771–781. doi: 10.1016/j.jcmgh.2020.09.017.
  • Dezzutti CS, Uranker K, Bunge KE, Richardson-Harman N, Macio I, Hillier SL. 2013. HIV-1 infection of female genital tract tissue for use in prevention studies. J Acquir Immune Defic Syndr. 63(5):548–554. doi: 10.1097/QAI.0b013e318291f331.
  • Di Teodoro G, Valleriani F, Puglia I, Monaco F, Di Pancrazio C, Luciani M, Krasteva I, Petrini A, Marcacci M, D’Alterio N, et al. 2021. SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species. Vet Microbiol. 252:108933. doi: 10.1016/j.vetmic.2020.108933.
  • Dinh MH, Anderson MR, McRaven MD, Cianci GC, McCoombe SG, Kelley ZL, Gioia CJ, Fought AJ, Rademaker AW, Veazey RS, et al. 2015. Visualization of HIV-1 interactions with penile and foreskin epithelia: Clues for female-to-male HIV transmission. PLoS Pathog. 11(3):e1004729. doi: 10.1371/journal.ppat.1004729.
  • Else L, Penchala SD, Pillay AD, Seiphetlo TB, Lebina L, Callebaut C, Minhas S, Morley R, Rashid T, Martinson N, et al. 2022. Pre-clinical evaluation of tenofovir and tenofovir alafenamide for HIV-1 pre-exposure prophylaxis in foreskin tissue. Pharmaceutics. 14(6):1285. doi: 10.3390/pharmaceutics14061285.
  • Esch EW, Bahinski A, Huh D. 2015. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 14(4):248–260. doi: 10.1038/nrd4539.
  • Fahmi A, Brugger M, Demoulins T, Zumkehr B, Oliveira Esteves BI, Bracher L, Wotzkow C, Blank F, Thiel V, Baud D, et al. 2021. SARS-CoV-2 can infect and propagate in human placenta explants. Cell Rep Med. 2(12):100456. doi: 10.1016/j.xcrm.2021.100456.
  • Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, Conrad BCG, Kumar S, Toebben L, Schughart K, et al. 2023. Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Antiviral Res. 209:105475. doi: 10.1016/j.antiviral.2022.105475.
  • Falconi-McCahill A. 2019. Bacterial vaginosis: A clinical update with a focus on complementary and alternative therapies. J Midwifery Womens Health. 64(5):578–591. doi: 10.1111/jmwh.13013.
  • Fan C, Wu Y, Rui X, Yang Y, Ling C, Liu S, Liu S, Wang Y. 2022. Animal models for COVID-19: Advances, gaps and perspectives. Signal Transduct Target Ther. 7(1):220.
  • Färber I, Krüger J, Rocha C, Armando F, von Köckritz-Blickwede M, Pöhlmann S, Braun A, Baumgärtner W, Runft S, Krüger N. 2022. Investigations on SARS-CoV-2 susceptibility of domestic and wild animals using primary cell culture models derived from the upper and lower respiratory tract. Viruses. 14(4):828. doi: 10.3390/v14040828.
  • Fleischli FD, Morf F, Adlhart C. 2015. Skin concentrations of topically applied substances in reconstructed human epidermis (RHE) compared with human skin using in vivo confocal Raman microscopy. Chimia. 69(3):147–151. doi: 10.2533/chimia.2015.147.
  • Fox-Canale AM, Hope TJ, Martinson J, Lurain JR, Rademaker AW, Bremer JW, Landay A, Spear GT, Lurain NS. 2007. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 369(1):55–68. doi: 10.1016/j.virol.2007.07.008.
  • Franzen N, van Harten WH, Retel VP, Loskill P, van den Eijnden-van Raaij J, Ij M. 2019. Impact of organ-on-a-chip technology on pharmaceutical R&D costs. Drug Discov Today. 24(9):1720–1724. doi: 10.1016/j.drudis.2019.06.003.
  • Gabbanini S, Lucchi E, Carli M, Berlini E, Minghetti A, Valgimigli L. 2009. In vitro evaluation of the permeation through reconstructed human epidermis of essentials oils from cosmetic formulations. J Pharm Biomed Anal. 50(3):370–376. doi: 10.1016/j.jpba.2009.05.018.
  • Godin B, Touitou E. 2007. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 59(11):1152–1161. doi: 10.1016/j.addr.2007.07.004.
  • Grivel JC, Margolis L. 2009. Use of human tissue explants to study human infectious agents. Nat Protoc. 4(2):256–269. doi: 10.1038/nprot.2008.245.
  • Grivel JC, Penn ML, Eckstein DA, Schramm B, Speck RF, Abbey NW, Herndier B, Margolis L, Goldsmith MA. 2000. Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol. 74(11):5347–5351. doi: 10.1128/jvi.74.11.5347-5351.2000.
  • Haberland A, Schreiber S, Maia CS, Rubbelke MK, Schaller M, Korting HC, Kleuser B, Schimke I, Schafer-Korting M. 2006. The impact of skin viability on drug metabolism and permeation - BSA toxicity on primary keratinocytes. Toxicol in Vitro. 20(3):347–354. doi: 10.1016/j.tiv.2005.08.013.
  • Herrera C. 2019. The pre-clinical toolbox of pharmacokinetics and pharmacodynamics: In vitro and ex vivo models. Front Pharmacol. 10:578. doi: 10.3389/fphar.2019.00578.
  • Herrera C, Cottrell ML, Prybylski J, Kashuba ADM, Veazey RS, García-Pérez J, Olejniczak N, McCoy CF, Ziprin P, Richardson-Harman N, et al. 2022. The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans. iScience. 25(6):104409. doi: 10.1016/j.isci.2022.104409.
  • Herrera C, Cranage M, McGowan I, Anton P, Shattock RJ. 2011. Colorectal microbicide design: Triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants. AIDS. 25(16):1971–1979. doi: 10.1097/QAD.0b013e32834b3629.
  • Herrera C, Lwanga J, Lee M, Mantori S, Amara A, Else L, Penchala SD, Egan D, Challenger E, Dickinson L, et al. 2021. Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). J Antimicrob Chemother. 76(8):2129–2136. doi: 10.1093/jac/dkab136.
  • Herrera C, McRaven MD, Laing KG, Dennis J, Hope TJ, Shattock RJ. 2021. Early colorectal responses to HIV-1 and modulation by antiretroviral drugs. Vaccines. 9(3):231. doi: 10.3390/vaccines9030231.
  • Herrera C, Veazey R, Lemke MM, Arnold K, Kim JH, Shattock RJ. 2022. Ex vivo evaluation of mucosal responses to vaccination with ALVAC and AIDSVAX of non-human primates. Vaccines. 10(2):187. doi: 10.3390/vaccines10020187.
  • Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM. 2010. Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod. 82(3):617–627. doi: 10.1095/biolreprod.109.080408.
  • Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2):271–280 e278. doi: 10.1016/j.cell.2020.02.052.
  • Hou X, Hossini AM, Nikolakis G, Balthasar O, Kurtz A, Zouboulis CC. 2022. 3D-SeboSkin model for human ex vivo studies of Hidradenitis Suppurativa/Acne Inversa. Dermatology. 238(2):236–243. doi: 10.1159/000515955.
  • Hu T, Bailey RE, Morrall SW, Aardema MJ, Stanley LA, Skare JA. 2009. Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: Application of the EpiDerm human reconstructed epidermis model. Toxicol Lett. 188(2):119–129. doi: 10.1016/j.toxlet.2009.03.019.
  • Huh DD, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, Thorneloe KS, McAlexander MA, Ingber DE. 2012. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med. 4(159):159ra147. doi: 10.1126/scitranslmed.3004249.
  • Huh DD, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. 2010. Reconstituting organ-level lung functions on a chip. Science. 328(5986):1662–1668. doi: 10.1126/science.1188302.
  • Huh DD. 2015. A human breathing lung-on-a-chip. Ann Am Thorac Soc. 12(Suppl 1):S42–S44. doi: 10.1513/AnnalsATS.201410-442MG.
  • Hui KPY, Cheung M-C, Perera RAPM, Ng K-C, Bui CHT, Ho JCW, Ng MMT, Kuok DIT, Shih KC, Tsao S-W, et al. 2020. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: An analysis in ex vivo and in vitro cultures. Lancet Respir Med. 8(7):687–695. doi: 10.1016/S2213-2600(20)30193-4.
  • Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, Kam TT, Gu H, Sit KY, Hsin MKY, et al. 2022. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 603(7902):715–720. doi: 10.1038/s41586-022-04479-6.
  • Ingber DE. 2016. Reverse engineering human pathophysiology with organs-on-chips. Cell. 164(6):1105–1109. doi: 10.1016/j.cell.2016.02.049.
  • Ingber DE. 2022. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 23(8):467–491. doi: 10.1038/s41576-022-00466-9.
  • Jensen C, Teng Y. 2020. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci. 7:33. doi: 10.3389/fmolb.2020.00033.
  • Jeong M, Ocwieja KE, Han D, Wackym PA, Zhang Y, Brown A, Moncada C, Vambutas A, Kanne T, Crain R, et al. 2021. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med. 1(1):44. doi: 10.1038/s43856-021-00044-w.
  • Kandarova H, Liebsch M, Genschow E, Gerner I, Traue D, Slawik B, Spielmann H. 2004. Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX. 21(3):107–114.
  • Kashuba AD, Gengiah TN, Werner L, Yang KH, White NR, Karim QA, Abdool Karim SS. 2015. Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: Importance of adherence for microbicide effectiveness. J Acquir Immune Defic Syndr. 69(3):264–269. doi: 10.1097/QAI.0000000000000607.
  • Klatt NR, Cheu R, Birse K, Zevin AS, Perner M, Noel-Romas L, Grobler A, Westmacott G, Xie IY, Butler J, et al. 2017. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 356(6341):938–945. doi: 10.1126/science.aai9383.
  • Kruger N, Rocha C, Runft S, Kruger J, Farber I, Armando F, Leitzen E, Brogden G, Gerold G, Pohlmann S, et al. 2021. The upper respiratory tract of felids is highly susceptible to SARS-CoV-2 infection. Int J Mol Sci. 22(19):10636. doi: 10.3390/ijms221910636.
  • Langerak T, Broekhuizen M, Unger PA, Tan L, Koopmans M, van Gorp E, Danser AHJ, Rockx B. 2022. Transplacental Zika virus transmission in ex vivo perfused human placentas. PLoS Negl Trop Dis. 16(4):e0010359. doi: 10.1371/journal.pntd.0010359.
  • Lantz AM, Nicol MR. 2022. Translational models to predict target concentrations for pre-exposure prophylaxis in women. AIDS Res Hum Retroviruses. 38(12):909–923. doi: 10.1089/AID.2022.0057.
  • Lebonvallet N, Jeanmaire C, Danoux L, Sibille P, Pauly G, Misery L. 2010. The evolution and use of skin explants: Potential and limitations for dermatological research. Eur J Dermatol. 20(6):671–684.
  • Lent EM, Maistros KJ, Oyler JM. 2020. In vitro dermal absorption of carfentanil. Toxicol in Vitro. 62:104696. doi: 10.1016/j.tiv.2019.104696.
  • Limonta D, Branton W, Wong CP, Saito L, Power C, Hobman TC. 2020. Use of primary human fetal astrocytes and tissue explants as ex vivo models to study Zika virus infection of the developing brain. Methods Mol Biol. 2142:251–259. doi: 10.1007/978-1-0716-0581-3_19.
  • Lombardi Borgia S, Schlupp P, Mehnert W, Schafer-Korting M. 2008. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Eur J Pharm Biopharm. 68(2):380–389. doi: 10.1016/j.ejpb.2007.05.003.
  • Lopez H, Benard M, Saint-Aubert E, Baron M, Martin H, Al Saati T, Plantavid M, Duga-Neulat I, Berrebi A, Cristini C, et al. 2011. Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity. Placenta. 32(7):522–530. doi: 10.1016/j.placenta.2011.04.016.
  • Maboni G, Davenport R, Sessford K, Baiker K, Jensen TK, Blanchard AM, Wattegedera S, Entrican G, Totemeyer S. 2017. A novel 3D skin explant model to study anaerobic bacterial infection. Front Cell Infect Microbiol. 7:404. doi: 10.3389/fcimb.2017.00404.
  • Machado D, Gaspar C, Palmeira-de-Oliveira A, Cavaleiro C, Salgueiro L, Martinez-de-Oliveira J, Cerca N. 2017. Thymbra capitata essential oil as potential therapeutic agent against Gardnerella vaginalis biofilm-related infections. Future Microbiol. 12(5):407–416. doi: 10.2217/fmb-2016-0184.
  • Marrazzo JM, Rabe L, Kelly C, Richardson B, Deal C, Schwartz JL, Chirenje ZM, Piper J, Morrow RA, Hendrix CW, et al. 2019. Tenofovir gel for prevention of herpes simplex virus type 2 acquisition: Findings from the VOICE trial. J Infect Dis. 219(12):1940–1947. doi: 10.1093/infdis/jiz045.
  • Martinson N, Gordhan B, Petkov S, Pillay AD, Seiphetlo T, Singh N, Otwombe K, Lebina L, Fredolini C, Chiodi F, et al. 2023. Proteomic analysis of mucosal and systemic responses to SARS-CoV-2 antigen. Vaccines. 11(2):334. doi: 10.3390/vaccines11020334.
  • Maurin C, He Z, Mentek M, Verhoeven P, Pillet S, Bourlet T, Rogues F, Pugniet JL, Peyragrosse T, Barallon M, et al. 2022. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study. PLoS Med. 19(3):e1003922. doi: 10.1371/journal.pmed.1003922.
  • Mavon A, Raufast V, Redoules D. 2004. Skin absorption and metabolism of a new vitamin E prodrug, δ-tocopherol-glucoside: In vitro evaluation in human skin models. J Control Release. 100(2):221–231. doi: 10.1016/j.jconrel.2004.08.012.
  • Mesquita PM, Rastogi R, Segarra TJ, Teller RS, Torres NM, Huber AM, Kiser PF, Herold BC. 2012. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother. 67(7):1730–1738. doi: 10.1093/jac/dks097.
  • Monti D, Brini I, Tampucci S, Chetoni P, Burgalassi S, Paganuzzi D, Ghirardini A. 2008. Skin permeation and distribution of two sunscreens: A comparison between reconstituted human skin and hairless rat skin. Skin Pharmacol Physiol. 21(6):318–325. doi: 10.1159/000154927.
  • Morgan P, Brown DG, Lennard S, Anderton MJ, Barrett JC, Eriksson U, Fidock M, Hamren B, Johnson A, March RE, et al. 2018. Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nat Rev Drug Discov. 17(3):167–181. doi: 10.1038/nrd.2017.244.
  • Murer L, Volle R, Andriasyan V, Petkidis A, Gomez-Gonzalez A, Yang L, Meili N, Suomalainen M, Bauer M, Policarpo Sequeira D, et al. 2022. Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern. Curr Res Virol Sci. 3:100019. doi: 10.1016/j.crviro.2022.100019.
  • Nash S, Dietrich J, Ssemata AS, Herrera C, O’Hagan K, Else L, Chiodi F, Kelly C, Shattock R, Chirenje M, et al. 2020. Combined HIV Adolescent Prevention Study (CHAPS): Comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial. Trials. 21(1):900. doi: 10.1186/s13063-020-04760-x.
  • Nickerson CA, Richter EG, Ott CM. 2007. Studying host-pathogen interactions in 3-D: Organotypic models for infectious disease and drug development. J Neuroimmune Pharmacol. 2(1):26–31. doi: 10.1007/s11481-006-9047-x.
  • Ouattara LA, Vann NC, Doncel GF. 2022. Ex vivo HIV infection model of cervico-vaginal and rectal tissue. Methods Mol Biol. 2407:157–172. doi: 10.1007/978-1-0716-1871-4_12.
  • Pedreno-Lopez S, Garcia E, Guerrero D, Gomez-Mora E, Molina Mateu L, Orera Perez F, Senserrich J, Clotet B, Cabrera C. 2022. Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo. Sci Rep. 12(1):7439. doi: 10.1038/s41598-022-11181-0.
  • Pedrosa AF, Lisboa C, Branco J, Pellevoisin C, Miranda IM, Rodrigues AG. 2019. Malassezia interaction with a reconstructed human epidermis: Keratinocyte immune response. Mycoses. 62(10):932–936. doi: 10.1111/myc.12965.
  • Plesniarski A, Siddik AB, Su RC. 2021. The microbiome as a key regulator of female genital tract barrier function. Front Cell Infect Microbiol. 11:790627. doi: 10.3389/fcimb.2021.790627.
  • Rajan A, Weaver AM, Aloisio GM, Jelinski J, Johnson HL, Venable SF, McBride T, Aideyan L, Piedra FA, Ye X, et al. 2021. The human nose organoid respiratory virus model: An ex vivo human challenge model to study respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis and evaluate therapeutics. mBio. 13(1):e0351121. doi: 10.1128/mbio.03511-21.
  • Ribeiro MR, Moreli JB, Marques RE, Papa MP, Meuren LM, Rahal P, de Arruda LB, Oliani AH, Oliani D, Oliani SM, et al. 2018. Zika-virus-infected human full-term placental explants display pro-inflammatory responses and undergo apoptosis. Arch Virol. 163(10):2687–2699. doi: 10.1007/s00705-018-3911-x.
  • Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y, Gai F, Billitto N, Lynam JD, Pryke K, Graebing P, et al. 2010. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One. 5(2):e9310. doi: 10.1371/journal.pone.0009310.
  • Rosca AS, Castro J, Sousa LGV, Franca A, Cavaleiro C, Salgueiro L, Cerca N. 2022. Six bacterial vaginosis-associated species can form an in vitro and ex vivo polymicrobial biofilm that is susceptible to Thymbra capitata essential oil. Front Cell Infect Microbiol. 12:824860. doi: 10.3389/fcimb.2022.824860.
  • Schafer-Korting M, Bock U, Diembeck W, Dusing HJ, Gamer A, Haltner-Ukomadu E, Hoffmann C, Kaca M, Kamp H, Kersen S, et al. 2008. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern Lab Anim. 36(2):161–187. doi: 10.1177/026119290803600207.
  • Schaller MA, Sharma Y, Dupee Z, Nguyen D, Uruena J, Smolchek R, Loeb JC, Machuca TN, Lednicky JA, Odde DJ, et al. 2021. Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses. JCI Insight. 6(18):e148003. doi: 10.1172/jci.insight.148003.
  • Schmook FP, Meingassner JG, Billich A. 2001. Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. Int J Pharm. 215(1-2):51–56. doi: 10.1016/s0378-5173(00)00665-7.
  • Schulze J, Mache C, Balazs A, Frey D, Niemeyer D, Olze H, Dommerich S, Drosten C, Hocke AC, Mall MA, et al. 2021. Analysis of severe acute respiratory syndrome 2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses. J Infect Dis. 224(12):2020–2024. doi: 10.1093/infdis/jiab523.
  • Shen JX, Youhanna S, Zandi Shafagh R, Kele J, Lauschke VM. 2020. Organotypic and microphysiological models of liver, gut, and kidney for studies of drug metabolism, pharmacokinetics, and toxicity. Chem Res Toxicol. 33(1):38–60. doi: 10.1021/acs.chemrestox.9b00245.
  • Smith SA, Murray PM, Amancha PK, Ackerley CG, Hu YJ, Amara RR, Kelley CF. 2020. Ex vivo rectal explant model reveals potential opposing roles of natural killer cells and marginal zone-like B cells in HIV-1 infection. Sci Rep. 10(1):20154. doi: 10.1038/s41598-020-76976-5.
  • Sufiawati I, Herrera R, Mayer W, Cai X, Borkakoti J, Lin V, Rosbe K, Tugizov SM. 2021. Human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) coinfection of infant tonsil epithelium may synergistically promote both HIV-1 and HCMV spread and infection. J Virol. 95(18):e0092121. doi: 10.1128/JVI.00921-21.
  • Sugibayashi K, Hayashi T, Matsumoto K, Hasegawa T. 2004. Utility of a three-dimensional cultured human skin model as a tool to evaluate the simultaneous diffusion and metabolism of ethyl nicotinate in skin. Drug Metab Pharmacokinet. 19(5):352–362. doi: 10.2133/dmpk.19.352.
  • Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, Liu SS, Zhang NN, Li XF, Xiong R, et al. 2020. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 28(1):124–133 e124. doi: 10.1016/j.chom.2020.05.020.
  • Swidsinski A, Dorffel Y, Loening-Baucke V, Schilling J, Mendling W. 2011. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. FEMS Immunol Med Microbiol. 61(1):41–46. doi: 10.1111/j.1574-695X.2010.00743.x.
  • Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dorffel Y, Scholze J, Lochs H, Verstraelen H. 2008. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 198(1):97 e91–97.e6. doi: 10.1016/j.ajog.2007.06.039.
  • Tallarek AC, Urbschat C, Fonseca Brito L, Stanelle-Bertram S, Krasemann S, Frascaroli G, Thiele K, Wieczorek A, Felber N, Lutgehetmann M, et al. 2021. Inefficient placental virus replication and absence of neonatal cell-specific immunity upon SARS-CoV-2 infection during pregnancy. Front Immunol. 12:698578. doi: 10.3389/fimmu.2021.698578.
  • Tulinski P, Duim B, Wittink FR, Jonker MJ, Breit TM, van Putten JP, Wagenaar JA, Fluit AC. 2014. Staphylococcus aureus ST398 gene expression profiling during ex vivo colonization of porcine nasal epithelium. BMC Genomics. 15(1):915. doi: 10.1186/1471-2164-15-915.
  • Tulinski P, Fluit AC, Wagenaar JA, Mevius D, van de Vijver L, Duim B. 2012. Methicillin-resistant coagulase-negative staphylococci on pig farms as a reservoir of heterogeneous staphylococcal cassette chromosome mec elements. Appl Environ Microbiol. 78(2):299–304. doi: 10.1128/AEM.05594-11.
  • Volle R, Murer L, Petkidis A, Andriasyan V, Savi A, Bircher C, Meili N, Fischer L, Sequeira DP, Mark DK, et al. 2022. Methylene blue, mycophenolic acid, posaconazole, and niclosamide inhibit SARS-CoV-2 Omicron variant BA.1 infection of human airway epithelial organoids. Curr Res Microb Sci. 3:100158. doi: 10.1016/j.crmicr.2022.100158.
  • Wang Y, Wang P, Qin J. 2021. Microfluidic organs-on-a-chip for modeling human infectious diseases. Acc Chem Res. 54(18):3550–3562. doi: 10.1021/acs.accounts.1c00411.
  • Weisblum Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, Zakay-Rones Z, Meir K, Shveiky D, Elgavish S, Nevo Y, Roseman M, et al. 2017. Zika virus infects early- and midgestation human maternal decidual tissues, inducing distinct innate tissue responses in the maternal-fetal interface. J Virol. 91(4):e01905–01916. doi: 10.1128/JVI.01905-16.
  • Youhanna S, Wright SC, Lauschke VM. 2021. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development. Curr Opin Pharmacol. 59:11–18. doi: 10.1016/j.coph.2021.04.006.
  • Yuen CK, Wong WM, Mak LF, Wang X, Chu H, Yuen KY, Kok KH. 2021. Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase. J Med Virol. 93(4):2076–2083. doi: 10.1002/jmv.26583.
  • Zimniak M, Kirschner L, Hilpert H, Geiger N, Danov O, Oberwinkler H, Steinke M, Sewald K, Seibel J, Bodem J. 2021. The serotonin reuptake inhibitor fluoxetine inhibits SARS-CoV-2 in human lung tissue. Sci Rep. 11(1):5890. doi: 10.1038/s41598-021-85049-0.
  • Zscheppang K, Berg J, Hedtrich S, Verheyen L, Wagner DE, Suttorp N, Hippenstiel S, Hocke AC. 2018. Human pulmonary 3D models for translational research. Biotechnol J. 13(1):1700341. doi: 10.1002/biot.201700341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.